The Antidepressant Effect of Repeat Dose Intravenous Ketamine Is Delayed by Concurrent Benzodiazepine Use
The DOI matches its Crossref record.
Abstract
Article AbstractBecause this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.To the Editor: Standard pharmacologic treatment options for depressive symptoms are generally unable to achieve remission quickly. This delay may account for the substantial morbidity and mortality associated with unremitted depression. The discovery of the rapid-acting antidepressant effects of ketamine has generated significant interest and led to ketamine being labeled "the most important discovery in half a century."
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another consideration supporting cognition as a key driver of ketamine response could be the potential decreased efficacy of ketamine clinically when benzodiazepines (which are known to impair cognitive processes) are co-administered.182–184”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [184]
In the citing paper
“Indeed, there are significant overlaps in the cognitive dysfunction pattern between chronic ketamine and methamphetamine users.182–188”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [184]
Citations
Cites
Still being checked.
Cited by
McIntyre, R. S., Rosenblat, J. D., Nemeroff, C. B., Sanacora, G., Murrough, J. W., Berk, M., Brietzke, E., Dodd, S., Gorwood, P., Ho, R., et al. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20081251 · Cited by 731
Matveychuk, D., Thomas, R. K., Swainson, J., Khullar, A., MacKay, M.-A., Baker, G. B., & Dursun, S. M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320916657 · Cited by 209
An update on ketamine and its two enantiomers as rapid-acting antidepressants
Zhang, K., & Hashimoto, K. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1554434 · Cited by 132
Ketamine: Mechanisms and Relevance to Treatment of Depression
Kim, J., Suzuki, K., Kavalali, E. T., & Monteggia, L. M. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-051322-120608 · Cited by 148
Long-term safety of ketamine and esketamine in treatment of depression
Nikayin, S., Murphy, E., Krystal, J. H., & Wilkinson, S. T. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2066651 · Cited by 120
Shiroma, P. R., Thuras, P., Wels, J., Albott, C. S., Erbes, C., Tye, S., & Lim, K. O. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00897-0 · Cited by 112
Self-citationZhou, Y., Lan, X., Wang, C., Zhang, F., Liu, H., Fu, L., Li, W., Ye, Y., Hu, Z., Chao, Z., et al. (2023) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2023.05.031 · Cited by 65
Feeney, A., & Papakostas, G. I. (2023) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2023.02.003 · Cited by 65
The Antidepressant Effect of Ketamine Is Dampened by Concomitant Benzodiazepine Medication
Andrashko, V., Novak, T., Brunovsky, M., Klirova, M., Sos, P., & Horacek, J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00844 · Cited by 48
Veraart, J. K. E., Smith-Apeldoorn, S. Y., Bakker, I. M., Visser, B. A. E., Kamphuis, J., Schoevers, R. A., & Touw, D. J. (2021) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab039 · Cited by 43
Personalized use of ketamine and esketamine for treatment-resistant depression
Medeiros, G. C., Demo, I., Goes, F. S., Zarate, C. A., & Gould, T. D. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03180-8 · Cited by 51
Ketamine-Assisted Psychotherapy for PTSD Related to Racial Discrimination
Halstead, M., Reed, S., Krause, R., & Williams, M. T. (2021) · Clinical Case Studies · doi:10.1177/1534650121990894 · Cited by 42
Wilkowska, A., Włodarczyk, A., Gałuszko‐Węgielnik, M., Wiglusz, M. S., & Cubała, W. J. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s325000 · Cited by 41
Jha, M. K., Wilkinson, S. T., Krishnan, K., Collins, K. A., Sanacora, G., Murrough, J. W., Goes, F. S., Altinay, M. I., Aloysi, A. S., Asghar‐Ali, A. A., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.17786 · Cited by 45
Hassan, K., Struthers, W. M., Sankarabhotla, A., & Davis, P. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.992624 · Cited by 33
Pham, T. H., Defaix, C., Nguyen, T. M. L., Mendez‐David, I., Tritschler, L., David, D. J. P., & Gardier, A. M. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172913 · Cited by 30
Esketamine in depression: putative biomarkers from clinical research
Johnston, J. N., Zarate, C. A., & Kvarta, M. D. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01865-1 · Cited by 24
Diekamp, B., Borentain, S., Fu, D., Murray, R., Heerlein, K., Zhang, Q., Schüle, C., & Mathews, M. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s314874 · Cited by 18
Ketamine and Esketamine for Depression in Daily Practice: Opportunities and Challenges
Singh, B. (2024) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001898 · Cited by 20
Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and Psychedelic Approaches
Bennett, R., Yavorsky, C., & BRAVO, G. L. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.867484 · Cited by 16
Lan, X., Wang, C., Zhang, F., Liu, H., Fu, L., Li, W., Ye, Y., Hu, Z., Mai, S., Ning, Y., et al. (2023) · General Psychiatry · doi:10.1136/gpsych-2023-101007 · Cited by 19
Increased Demand for Ketamine Infusions and Associated Complexities
Peskin, E., Gudin, J. A., & Schatman, M. E. (2023) · Journal of Pain Research · doi:10.2147/jpr.s403323 · Cited by 16
Developing an IV Ketamine Clinic for Treatment-Resistant Depression: a Primer
Parikh, S. V., Lopez, D., Voort, J. L. V., Rico, J. A. Q., Achtyes, E. D., Coryell, W. H., Goddard, A. W., Goes, F. S., Greden, J. F., Singh, B., et al. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4413 · Cited by 20
Albott, C. S., Lim, K. O., Erbes, C. R., THURAS, P. D., Wels, J., Tye, S. J., & Shiroma, P. R. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.04.066 · Cited by 14
Self-citationBobo, W. V., Riva‐Posse, P., Goes, F. S., & Parikh, S. V. (2020) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20190048 · Cited by 14
Bottemanne, H., Claret, A., & Fossati, P. (2020) · L Encéphale · doi:10.1016/j.encep.2020.08.006 · Cited by 15
Wang, Y., Xu, J., Zhou, X., Che, L., Qiu, M., Liu, Y., Gao, M., & Yang, Z. (2025) · Advanced Science · doi:10.1002/advs.202516024 · Cited by 13
Psychothérapie augmentée par la kétamine (KAP) dans les troubles de l’humeur : mode d’emploi
Bottemanne, H., Baldacci, A., Muller, C., Boyreau, A., & Claret, A. (2021) · L Encéphale · doi:10.1016/j.encep.2021.08.011 · Cited by 13
Stamenković, D., Selvaraj, S., Venkatraman, S., Arshad, A., Rančić, N., Dragojevic-Simic, V. M., Miljković, M. N., & Cattano, D. (2020) · Minerva Anestesiologica · doi:10.23736/s0375-9393.20.14259-7 · Cited by 10
Irwin, M. N., & VandenBerg, A. (2021) · Mental Health Clinician · doi:10.9740/mhc.2021.05.200 · Cited by 7
Ketamine for postoperative avoidance of depressive symptoms: the K-PASS feasibility randomised trial
Fritz, B. A., Pennington, B. R. T., Dalton, C., Horan, C., Palanca, B. J. A., Schweiger, J. A., Griffin, L., Tumwesige, W., Willie, J. T., & Farber, N. B. (2023) · BJA Open · doi:10.1016/j.bjao.2023.100245 · Cited by 5
Concurrent benzodiazepines undermine the antidepressant effect of ketamine
Andrashko, V., Novák, T., Horáček, J., Klírová, M., & Brunovský, M. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.11.592 · Cited by 5
Murata, S., Madaj, Z., Capan, C. D., Sheldon, R. D., El‐Mallakh, R. S., Parikh, S. V., Bobo, W. V., Goes, F. S., Wolkowitz, O. M., Voort, J. L. V., et al. (2025) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2025.100503 · Cited by 7
Pereira, M. S., Anzolin, A. P., Londero, M. D. B., Zegarra, N. R. M., Pranke, M. A., & Cruz, L. N. (2023) · Psychiatry Research Case Reports · doi:10.1016/j.psycr.2023.100116 · Cited by 1
Identification and management of anxious depression in patients with treatment-resistant depression
Hershenberg, R., Rapaport, M. H., & Weischedel, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00029-3 · Cited by 3
Kang, M. J. Y. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821033-8.00002-2 · Cited by 1
How to implement a ketamine clinic
Chandrasena, R. D., Fairbairn, J., Kang, M. J. Y., & Vázquez, G. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821033-8.00006-x
Ketamina eta esketaminaren erabilera depresioerresistentea tratatzeko: etorkizunerako erronkak
Elexpe, A., Bruzos-Cidón, C., Cabrera, M., Barreda‐Gómez, G., & Torrecilla, M. (2020) · EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria · doi:10.1387/ekaia.21862
Woodruff, S., Hibicke, M., & Nichols, C. D. (2025) · Psychedelic Medicine · doi:10.1177/28314425251393186
Atídio, J. P., Delfino, R. S., Garios, I. S., de Brito, C. S. G. F., Gerheim, Y. P., Vasconcelos, G. M. D. A. E., Piloto, R., Ferro, M. D., Júnior, R. O. P. D. S., Surjan, J. C., et al. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121721
Duncan, E., Hersant, H., & Khairova, R. A. (2026) · Springer eBooks · doi:10.1007/978-3-032-15772-0_4
Angel, M. (2026) · Case Reports in Psychiatry · doi:10.1155/crps/6450306
Castro, A. M. (2026) · UCrea (University of Cantabria)
Metadata
- Authors
- Albott, C. S., Shiroma, P. R., Cullen, K. R., Johns, B., Thuras, P., Wels, J., & Lim, K. O.
- Affiliations
- University of Minnesota (US)
- North Memorial Medical Center (US)
- Minneapolis VA Medical Center (US)
- Minneapolis VA Health Care System (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2017-03-29
- Volume
- 78
- Issue
- 3
- Pages
- e308-e309
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2601818980
- Cited by
- 42
- References
- 0
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 7 · 2022: 5 · 2021: 7 · 2020: 10 · 2019: 1 · 2018: 1
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- ketamine, benzodiazepines, antidepressant effects, rapid-acting antidepressants, depression, drug interactions, intravenous administration
- MeSH terms
- Adolescent, Adult, Aged, Antidepressive Agents, Benzodiazepines, Drug Administration Schedule, Drug Interactions, Drug Therapy, Combination, Female, Humans, Infusions, Intravenous, Ketamine, Male, Middle Aged, Treatment Outcome, Young Adult, Depressive Disorder, Treatment-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.